Your Article Summary
See Latest ArticlesMedtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Medtronic, 06/25/09
Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted. Medtronic Inc. announces two significant clinical trials related to medical device interventions for stroke. First enrollments in the global CRYSTAL AF trial have taken place. The trial will use the Reveal XT Insertable Cardiac Monitor to assess the incidence of atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack in order to aid physicians in determining the optimal course of treatment for these patients.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis
Roche, 12/14/09
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease
Clinical Drug Investigation, 12/14/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/14/09
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)
Movement Disorders, 12/14/09
Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Dementia and Geriatric Cognitive Disorders, 12/14/09